|
Market Cap (4-Jul) $2,051,017,728 (333rd) |
Close (30-Jun) $1.14 |
Volume (30-Jun) 2,606,681 |
Shortsold (19-Jun) 79,324,475 (6.21%) (26th) |
|
52w High $3.37 |
52w Low $0.88 |
P/E 454.55 |
EPS -0.14 |
MSB released this announcement to the ASX on 21 June 2022, 9:54. The announcement is not marked as price sensitive, and is 30 page(s) in length and 6.92MB in size.
You can view all announcements from MSB and see how they appear on a price chart on the announcements page.
At the date of this announcement, MSB was 8.019% short sold according to ASIC data. It was ranked the 11th most shorted stock on the ASX. It remains ranked 26th as of the latest reported data (19 June 2025).
| Other Recent Announcements from MSB | |
|---|---|
| Change of Director's Interest Notice | 13 June 2023, 8:56 |
| Mesoblast Director Appointed to Strategic Advisory Role | 5 June 2023, 9:41 |
| MSB Reports Q3 Financial Results and Operational Highlights | 26 May 2023, 8:32 |
| Chronic Low Back Pain KOL Event Presentation | 21 June 2022, 9:54 |
| Litigation Update | 14 June 2022, 10:11 |
| Mesoblast to Host KOL Event on Chronic Low Back Pain | 9 June 2022, 9:34 |
| Third Quarter Results Presentation | 1 June 2022, 9:34 |
You must be logged in to post a reply.
Mesoblast 